PF-05139962, identified by its CAS number 1393712-18-9, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure typically includes functional groups that enhance its solubility and bioavailability, making it suitable for oral administration. In preclinical studies, PF-05139962 has demonstrated promising results in modulating target proteins involved in disease processes, although detailed pharmacokinetic and pharmacodynamic profiles are essential for understanding its behavior in biological systems. Safety and toxicity assessments are crucial in the development of this compound, as they determine its viability for clinical use. Overall, PF-05139962 represents a significant area of interest in drug discovery, with ongoing research aimed at elucidating its full potential and mechanisms of action.

PF-05139962

1393712-18-9: PF-05139962, identified by its CAS number 1393712-18-9, is a chemical compound that has garnered attention in pharmaceutical research, particularly for its potential therapeutic applications. It is classified as a small molecule and is known to act as a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's structure typically includes functional groups that enhance its solubility and bioavailability, making it suitable for oral administration. In preclinical studies, PF-05139962 has demonstrated promising results in modulating target proteins involved in disease processes, although detailed pharmacokinetic and pharmacodynamic profiles are essential for understanding its behavior in biological systems. Safety and toxicity assessments are crucial in the development of this compound, as they determine its viability for clinical use. Overall, PF-05139962 represents a significant area of interest in drug discovery, with ongoing research aimed at elucidating its full potential and mechanisms of action.

<p>PF-05139962: potent mTOR inhibitor, IC50=48nM/6nM, kinase-selective, good ADME, non-genotoxic, CYP-safe, LE=0.35, LipE=6.8.</p>

CAS 1393712-18-9

PF-05139962

PF-05139962

Ref: TM-T70782